Gametocyte infectivity by direct mosquito feeds in an area of seasonal malaria transmission: implications for Bancoumana, Mali as a transmission-blocking vaccine site

Am J Trop Med Hyg. 1998 Sep;59(3):481-6. doi: 10.4269/ajtmh.1998.59.481.

Abstract

Infectivity of gametocytemic volunteers living in Bancoumana, a village 60 km from Bamako, Mali, was determined by direct feeds of laboratory-reared Anopheles gambiae s. l. Gametocytemic adolescents (10-18 years old) were as infectious to mosquitoes as younger volunteers and appear to be a more suitable population for testing transmission-blocking efficacy as compared with adults (> 18 years old). To begin to validate the membrane-feeding assay, sera collected from these same volunteers were subjected to a standard membrane-feeding assay. The data suggest that areas with intense but seasonal transmission might be feasible sites for testing transmission-blocking vaccines because of the high gametocytemic rates, high mosquito infectivity rates, and lack of pre-existing humoral-mediated transmission-blocking activity. The differences observed between field-based direct mosquito feeds and laboratory-based membrane feeding assays suggests that caution be used in interpreting Phase I study results in which laboratory-based membrane-feeding assays are used as a surrogate for vaccine efficacy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Animals
  • Anopheles / parasitology
  • Antibodies, Protozoan / blood
  • Child
  • Child, Preschool
  • Humans
  • Insect Vectors / parasitology
  • Malaria Vaccines* / immunology
  • Malaria, Falciparum / epidemiology
  • Malaria, Falciparum / prevention & control
  • Malaria, Falciparum / transmission*
  • Mali / epidemiology
  • Parasitemia / epidemiology
  • Parasitemia / prevention & control
  • Parasitemia / transmission*
  • Plasmodium falciparum / immunology
  • Plasmodium falciparum / pathogenicity*
  • Prevalence
  • Seasons

Substances

  • Antibodies, Protozoan
  • Malaria Vaccines